FDA.reportPublic FDA data

hyaluronidase, human recombinant 2400 UNT in 15 ML Injection

RxCUI
1809538
RxNorm name
hyaluronidase, human recombinant 2400 UNT in 15 ML Injection
Display name
hyaluronidase, human recombinant 2400 UNT in 15 ML Injection
Full name
hyaluronidase, human recombinant 2400 UNT in 15 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125402HyqviaImmune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7ca2c26f-4be2-48cd-be5b-486e350654bahyaluronidase, human recombinant 2400 UNT in 15 ML InjectionPSN22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204
7ca2c26f-4be2-48cd-be5b-486e350654ba15 ML hyaluronidase, human recombinant 160 UNT/ML InjectionSCD22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204
7ca2c26f-4be2-48cd-be5b-486e350654bahyaluronidase, human recombinant 2400 UNT per 15 ML InjectionSY22These highlights do not include all the information needed to use HYQVIA ® safely and effectively. See full prescribing information for HYQVIA. HYQVIA ® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration Initial U.S. Approval: 201420260204